Results 141 to 150 of about 462,808 (314)
Objective This nationwide descriptive study examined temporal trends in adverse pregnancy outcomes (APOs) and treatments in systemic lupus erythematosus (SLE) pregnancies in Sweden over 2003 to 2022. Methods Using nationwide Swedish registers, we identified 1,417 pregnancies of women with prevalent SLE and delivery dates in 2003 to 2022 and matched ...
Ngoc V. Nguyen +6 more
wiley +1 more source
Zhiqiang Cao,1,* Bin Peng,1,* Zonghao Li,2 Ruiqi Li,1 Ruitao Fan,1 Baibing Mi,2 Bingjie Li,1 Xiangjin Song,1 Jing Shi,1 Songmei Geng1 1Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated of Xi’an Jiaotong ...
Cao Z +9 more
doaj
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro +17 more
wiley +1 more source
Xiaojie Liu,1,* Chuanjian Yuan,2,* Yuan Kang,3,* Jun Zhang,1 Yibo Li,1 Ruiqi Wang,1 Chen Ding,1 Junling Zhang,1,* Weibin Xing1,* 1Department of Dermatology, Affiliated Hospital of Tianjin Academy of Traditional ...
Liu X +8 more
doaj
Objective Cardiac involvement is a major cause of morbidity in systemic lupus erythematosus (SLE). Tumor necrosis factor–like weak inducer of apoptosis (TWEAK) is elevated in SLE, but its contribution to lupus‐associated cardiac injury is unclear. We investigated the role of TWEAK/fibroblast growth factor–inducible 14 (Fn14) signaling in SLE‐related ...
Yale Liu +12 more
wiley +1 more source
The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis
Yanhua Liang,1 Baoqing Deng,2 Epipode Ntawuyamara,3 Hervé Bachelez,4 Fuxi Wang,5 Hao Zhang,6 Zhenying Zhang,7 Zhengfeng Li,7 Lin Dang,8 Yajie Wang,1 Xianbiao Zou,9 Li Wang,10 Dejian Duan,11 Hongxiang Chen,12 Wenjun Zheng,13 Hui Huang,14 Min Zhang,15 ...
Liang Y +22 more
doaj
Congenital Hypotrichosis in a female Rottweiler [PDF]
Ihrke, P. J. +2 more
core +1 more source
History of Dermatology, Dermatopathology, Dermatologic Surgery, Cosmetic Dermatology, and Pediatric Dermatology [PDF]
Allen F. Shih +2 more
openaire +1 more source
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola +14 more
wiley +1 more source

